The PROTAC ARV-825 was antiproliferative in a panel of 13 multiple myeloma (MM) cell lines, led to cell cycle arrest and apoptosis, and quickly degraded BRD2 and BRD4 accompanied by suppression of MYB and MYC. This evidence concerns the gene MYC and plasma cell myeloma.